The Cochrane Airways Group (CAG) is one of 52 Cochrane Review Groups, and we are part of The Cochrane Collaboration, an international not-for-profit organisation made up of over 20,000 volunteer and funded contributors worldwide. Each of The Cochrane Collaboration’s review groups is responsible for co-ordinating the preparation of systematic reviews in a particular area of healthcare. The CAG supports the preparation and maintenance of systematic reviews of interventions for managing chronic airways disease such as asthma and chronic obstructive pulmonary disease (COPD). 

The Cochrane Collaboration aims to make up-to-date, accurate information about the effects of healthcare readily available by publishing systematic reviews of the effects of healthcare interventions. These systematic reviews are published in the Cochrane Database of Systematic Reviews as Cochrane reviews, forming part of The Cochrane Library. The editorial office of the CAG is based at St George's University of London in South London, UK. We are funded by the UK government's Department of Health via its research funding body, the National Institute of Health Research. From our editorial office we co-ordinate support for author teams by organizing and providing training, running literature searches, and by providing methodological input with Cochrane reviews. We also manage the editorial and peer review of Cochrane reviews prior to publication on The Cochrane Library. 

The CAG maintains a specialized register of controlled trials in chronic airways disease which is made available in the Cochrane Central Register of Controlled Trials (CENTRAL), also published on The Cochrane Library.

Instructions for registering a title with the CAG are provided in the Airways Group resources page.